嘉和生物-B(06998)盘中大涨6.43%,引发市场关注。此前,嘉和生物与亿腾医药宣布了一项合并协议,这被认为是导致该股大涨的主要原因。
根据协议内容,亿腾医药将收购港交所上市公司嘉和生物,双方实现整合。这意味着亿腾医药借此机会实现上市,而嘉和生物则可获得亿腾在商业化运营方面的实力支持。
业内人士认为,合并后的新公司将进一步提升研发和商业化能力。嘉和生物拥有丰富的15大在研管线和重磅产品储备,而亿腾医药则拥有遍布全国的销售网络和稳健的现金流。通过优势互补,新公司研发和商业化发展均将获得提升,市场竞争力将大大增强。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.